comparemela.com

Latest Breaking News On - Maxcyte - Page 14 : comparemela.com

Investegate |MaxCyte, Inc. Announcements | MaxCyte, Inc.: Establishment of New Scientific Advisory Board

Investegate announcements from MaxCyte, Inc., Establishment of New Scientific Advisory Board

New-york
United-states
Memorial-sloan-kettering-cancer-center
Massachusetts-institute-of-technology
Massachusetts
United-kingdom
Rockville
California
Zurich
Züsz
Switzerland
Cambridge

Investegate |MaxCyte, Inc. Announcements | MaxCyte, Inc.: Preliminary Unaudited Q4 &FY 2022 Revenue Results

Investegate announcements from MaxCyte, Inc., Preliminary Unaudited Q4 &FY 2022 Revenue Results

United-kingdom
David-deuchler
Doug-doerfler
Mary-jane-elliott-chris-welsh
Emma-earl-freddy-crossley
Panmure-gordon
Rupert-dearden
Maxcyte-inc
Vertex-pharmaceuticals
Exchange-commission-on
Nasdaq
A-spectrum-science-company

MaxCyte revenue grows in 2022, expects further revenue climb in 2023

MaxCyte Inc on Tuesday announced a higher revenue for 2022, and said it anticipates revenue to grow further during 2023. The Maryland, US-based commercial cell-engineering company with an office in. | March 7, 2023

Maryland
United-states
Tom-budszus
Doug-doerfler
Vertex-pharmaceuticals
Alliance-news-ltd
Maxcyte-inc-on
Alliance-news
Cyte-inc
Chief-executive-officer-doug
All-rights
Maxcyte

Investegate |MaxCyte, Inc. Announcements | MaxCyte, Inc.: Notice of Results

Investegate announcements from MaxCyte, Inc., Notice of Results

United-kingdom
David-deuchler
Mary-jane-elliott-chris-welsh
Panmure-gordon
Emma-earl-freddy-crossley
Rupert-dearden
Maxcyte-inc
Digital-health
Gilmartin-group
Nasdaq
Consilium-strategic-communications
Report-fourth-quarter

Investegate |MaxCyte, Inc. Announcements | MaxCyte, Inc.: Exercise of options and PDMR dealing

Investegate announcements from MaxCyte, Inc., Exercise of options and PDMR dealing

United-kingdom
London
City-of
David-deuchler
Chris-welsh
Mary-jane-elliott
Doug-doerfler
Emma-earl-freddy-crossley
Panmure-gordon
Rupert-dearden
Maxcyte-inc
London-stock-exchange

vimarsana © 2020. All Rights Reserved.